Tom Chiller
Overview
Explore the profile of Tom Chiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
5913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cornely O, Sprute R, Bassetti M, Chen S, Groll A, Kurzai O, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39956121
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients...
2.
Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy
Purdie R, Kuran R, Alastruey-Izquierdo A, Sati H, Rodriguez-Tudela J, Hoenigl M, et al.
Mycopathologia
. 2025 Jan;
190(1):11.
PMID: 39775206
In the healthcare landscape, diseases such as cancer and HIV/AIDS have benefited from the patient's perspective. For fungal diseases, the patient voice remains absent in critical areas such as policy...
3.
Moussiegt A, Donald S, Bougnoux M, Eer M, Vreden S, Chiller T, et al.
Int J Infect Dis
. 2024 Dec;
153():107360.
PMID: 39672535
Objectives: Diagnosis of HIV-associated histoplasmosis remains challenging. Our objective was to compare the performances of (1→3)-β-D-Glucan (BDG) and aspergillus galactomannan (GM) antigen for the diagnosis of HIV-associated histoplasmosis. Methods: We...
4.
Smith D, Gold J, Williams S, Hennessee I, Jones S, Chiller T
Infect Dis Clin North Am
. 2024 Dec;
39(1):23-40.
PMID: 39638719
For this narrative review, we describe recent high-profile and severe outbreaks of emerging fungal infections, emphasizing lessons learned and opportunities to improve future prevention and response efforts. Several themes and...
5.
Akinlawon D, Osaigbovo I, Yahaya M, Makanjuola O, Udoh U, Nwajiobi-Princewill P, et al.
Int J Public Health
. 2024 Nov;
69:1607731.
PMID: 39611082
Objectives: To assess diagnostic mycology capacity and available fungal diagnostic services of microbiology laboratories in eight tertiary hospitals in Nigeria and one in Ghana. Methods: On-site audits were performed in...
6.
Zucker J, Caplan A, Gunaratne S, Gallitano S, Zampella J, Otto C, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Oct;
73(43):985-988.
PMID: 39480750
No abstract available.
7.
Hennessee I, Palmer S, Reik R, Miles-Jay A, Nawaz M, Blankenship H, et al.
Clin Infect Dis
. 2024 Oct;
80(2):356-363.
PMID: 39422247
Background: Blastomycosis is an environmentally acquired fungal infection that can result in severe pulmonary illness and high hospitalization rates. In 2023, a blastomycosis outbreak was detected among workers at a...
8.
Smith D, Queiroz-Telles F, Rabenja F, Hay R, Bonifaz A, Grijsen M, et al.
PLoS Negl Trop Dis
. 2024 Oct;
18(10):e0012562.
PMID: 39405322
Chromoblastomycosis, an implantation mycosis, is a neglected tropical disease that causes decreased quality of life, stigma, and disability. The global burden of disease is unknown and data on disease epidemiology...
9.
van Rhijn N, Arikan-Akdagli S, Beardsley J, Bongomin F, Chakrabarti A, Chen S, et al.
Lancet
. 2024 Sep;
404(10457):1017-1018.
PMID: 39277286
No abstract available.
10.
Bays D, Jenkins E, Lyman M, Chiller T, Strong N, Ostrosky-Zeichner L, et al.
Clin Epidemiol
. 2024 Sep;
16:549-566.
PMID: 39219747
Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast, . Previously, IC has predominantly been caused by which is often drug...